chr15-50948119-A-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_007347.5(AP4E1):​c.1276A>C​(p.Ile426Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,614,014 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 3 hom. )

Consequence

AP4E1
NM_007347.5 missense

Scores

1
4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 8.95

Publications

10 publications found
Variant links:
Genes affected
AP4E1 (HGNC:573): (adaptor related protein complex 4 subunit epsilon 1) This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
AP4E1 Gene-Disease associations (from GenCC):
  • AP-4 deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 51
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • AP4-related intellectual disability and spastic paraplegia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023585916).
BP6
Variant 15-50948119-A-C is Benign according to our data. Variant chr15-50948119-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 432244.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00106 (162/152364) while in subpopulation NFE AF = 0.00201 (137/68032). AF 95% confidence interval is 0.00174. There are 0 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP4E1NM_007347.5 linkc.1276A>C p.Ile426Leu missense_variant Exon 11 of 21 ENST00000261842.10 NP_031373.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP4E1ENST00000261842.10 linkc.1276A>C p.Ile426Leu missense_variant Exon 11 of 21 1 NM_007347.5 ENSP00000261842.5
AP4E1ENST00000560508.1 linkc.1051A>C p.Ile351Leu missense_variant Exon 11 of 21 1 ENSP00000452976.1
AP4E1ENST00000558439.5 linkn.*398A>C non_coding_transcript_exon_variant Exon 11 of 21 1 ENSP00000452712.1
AP4E1ENST00000561393.5 linkn.*320A>C non_coding_transcript_exon_variant Exon 10 of 20 1 ENSP00000452711.1
AP4E1ENST00000558439.5 linkn.*398A>C 3_prime_UTR_variant Exon 11 of 21 1 ENSP00000452712.1
AP4E1ENST00000561393.5 linkn.*320A>C 3_prime_UTR_variant Exon 10 of 20 1 ENSP00000452711.1

Frequencies

GnomAD3 genomes
AF:
0.00106
AC:
161
AN:
152246
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00200
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000884
AC:
222
AN:
251094
AF XY:
0.000862
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000694
Gnomad NFE exome
AF:
0.00161
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.00159
AC:
2319
AN:
1461650
Hom.:
3
Cov.:
31
AF XY:
0.00156
AC XY:
1134
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33466
American (AMR)
AF:
0.000291
AC:
13
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39642
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86254
European-Finnish (FIN)
AF:
0.000693
AC:
37
AN:
53372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00197
AC:
2191
AN:
1111916
Other (OTH)
AF:
0.00108
AC:
65
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
118
235
353
470
588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00106
AC:
162
AN:
152364
Hom.:
0
Cov.:
32
AF XY:
0.000819
AC XY:
61
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41590
American (AMR)
AF:
0.000196
AC:
3
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00201
AC:
137
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00137
Hom.:
0
Bravo
AF:
0.000895
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.00105
AC:
127
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00169
EpiControl
AF:
0.00142

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AP4E1: BS2 -

Apr 20, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26544806) -

Spastic paraplegia Uncertain:1
Jan 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 426 of the AP4E1 protein (p.Ile426Leu). This variant is present in population databases (rs148817957, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with AP4E1-related conditions (PMID: 26544806). ClinVar contains an entry for this variant (Variation ID: 432244). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
Jan 12, 2017
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Uncertain:1
Nov 01, 2017
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AP4E1-related disorder Benign:1
Apr 03, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.046
T;.
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.0085
T
MetaRNN
Benign
0.024
T;T
MetaSVM
Benign
-1.2
T
MutationAssessor
Benign
1.8
L;.
PhyloP100
8.9
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
0.27
N;N
REVEL
Benign
0.21
Sift
Benign
0.14
T;T
Sift4G
Benign
0.27
T;T
Polyphen
0.92
P;.
Vest4
0.54
MVP
0.17
MPC
0.31
ClinPred
0.055
T
GERP RS
5.8
Varity_R
0.43
gMVP
0.27
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148817957; hg19: chr15-51240316; COSMIC: COSV106085348; COSMIC: COSV106085348; API